Alexandra Balcom's most recent trade in Nuvalent Inc - Ordinary Shares - Class A was a trade of 131,637 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 131,637 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 84,200 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | 15 Jul 2026 | 44,433 | 0 | - | - | Class A Common Stock | ||
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 41,100 | 0 | - | - | Class A Common Stock - Restricted Stock Units | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 37,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 33,646 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 22,933 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 17,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2026 | 14,350 | 14,350 | - | 0 | Class A Common Stock - Performance Stock Units | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 14,350 | 0 | - | - | Class A Common Stock - Performance Stock Units | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Jul 2026 | 8,016 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 123.58 per share. | 01 Jul 2026 | 11,430 | 85,533 | - | 123.6 | 1,412,519 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 6,046 | 22,933 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 01 Jul 2026 | 6,046 | 96,963 | - | 18.9 | 114,451 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 01 Jul 2026 | 5,384 | 90,917 | - | 6.9 | 37,096 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2026 | 5,384 | 8,016 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2026 | 11,430 | 13,400 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 01 Jun 2026 | 11,430 | 96,963 | - | 6.9 | 78,753 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 99.86 per share. | 01 Jun 2026 | 3,133 | 88,600 | - | 99.9 | 312,861 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 100.65 per share. | 01 Jun 2026 | 2,588 | 86,012 | - | 100.6 | 260,482 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 95.99 per share. | 01 Jun 2026 | 2,170 | 93,833 | - | 96.0 | 208,298 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 98.57 per share. | 01 Jun 2026 | 1,200 | 91,733 | - | 98.6 | 118,284 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 94.87 per share. | 01 Jun 2026 | 960 | 96,003 | - | 94.9 | 91,075 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 97.68 per share. | 01 Jun 2026 | 900 | 92,933 | - | 97.7 | 87,912 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 101.79 per share. | 01 Jun 2026 | 279 | 85,733 | - | 101.8 | 28,399 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 103.84 per share. | 01 Jun 2026 | 200 | 85,533 | - | 103.8 | 20,768 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 99.29 per share. | 01 May 2026 | 7,434 | 85,657 | - | 99.3 | 738,122 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 01 May 2026 | 7,159 | 92,692 | - | 1.1 | 7,732 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2026 | 7,159 | 131,637 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2026 | 4,271 | 24,830 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 01 May 2026 | 4,271 | 96,963 | - | 6.9 | 29,427 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 98.42 per share. | 01 May 2026 | 3,872 | 93,091 | - | 98.4 | 381,082 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 99.97 per share. | 01 May 2026 | 124 | 85,533 | - | 100.0 | 12,396 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 01 Apr 2026 | 11,430 | 96,963 | - | 1.1 | 12,344 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 11,430 | 138,796 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 105.30 per share. | 01 Apr 2026 | 5,417 | 88,002 | - | 105.3 | 570,410 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 104.39 per share. | 01 Apr 2026 | 3,544 | 93,419 | - | 104.4 | 369,958 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 106.18 per share. | 01 Apr 2026 | 2,469 | 85,533 | - | 106.2 | 262,158 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 100.16 per share. | 24 Mar 2026 | 13,700 | 85,533 | - | 100.2 | 1,372,192 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2026 | 11,430 | 150,226 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 24 Mar 2026 | 11,430 | 110,663 | - | 1.1 | 12,344 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 95.88 per share. | 24 Mar 2026 | 7,671 | 100,393 | - | 95.9 | 735,495 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 95.03 per share. | 24 Mar 2026 | 2,599 | 108,064 | - | 95.0 | 246,983 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 96.50 per share. | 24 Mar 2026 | 1,160 | 99,233 | - | 96.5 | 111,940 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 17,500 | 99,233 | - | 0 | Class A Common Stock | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 97.96 per share. | 05 Jan 2026 | 1,929 | 85,231 | - | 98.0 | 188,965 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 97.33 per share. | 05 Jan 2026 | 1,635 | 81,958 | - | 97.3 | 159,135 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 96.75 per share. | 05 Jan 2026 | 1,321 | 83,593 | - | 96.8 | 127,807 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 96.85 per share. | 05 Jan 2026 | 1,119 | 87,160 | - | 96.8 | 108,375 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 96.06 per share. | 05 Jan 2026 | 871 | 88,279 | - | 96.1 | 83,668 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 98.52 per share. | 05 Jan 2026 | 317 | 84,914 | - | 98.5 | 31,231 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 98.40 per share. | 05 Jan 2026 | 225 | 81,733 | - | 98.4 | 22,140 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2025 | 34,500 | 161,656 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.08 per share. | 22 Dec 2025 | 34,500 | 89,150 | - | 1.1 | 37,260 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 110.31 per share. | 08 Dec 2025 | 6,984 | 54,750 | - | 110.3 | 770,405 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 111.32 per share. | 08 Dec 2025 | 100 | 54,650 | - | 111.3 | 11,132 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2025 | 13,125 | 34,375 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.35 per share. | 17 Nov 2025 | 13,125 | 81,734 | - | 72.4 | 949,594 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 17 Nov 2025 | 6,875 | 68,609 | - | 6.9 | 47,369 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2025 | 6,875 | 29,101 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 103.27 per share. | 17 Nov 2025 | 5,055 | 62,114 | - | 103.3 | 522,030 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 100.58 per share. | 17 Nov 2025 | 4,496 | 70,363 | - | 100.6 | 452,208 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 93.80 per share. | 17 Nov 2025 | 3,609 | 78,125 | - | 93.8 | 338,524 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 95.12 per share. | 17 Nov 2025 | 3,266 | 74,859 | - | 95.1 | 310,662 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 102.13 per share. | 17 Nov 2025 | 3,194 | 67,169 | - | 102.1 | 326,203 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2025 | 729 | 33,646 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.35 per share. | 17 Nov 2025 | 729 | 62,463 | - | 72.3 | 52,743 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 104.54 per share. | 17 Nov 2025 | 509 | 61,734 | - | 104.5 | 53,211 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 103.68 per share. | 17 Nov 2025 | 380 | 61,734 | - | 103.7 | 39,398 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 103.61 per share. | 17 Nov 2025 | 220 | 62,243 | - | 103.6 | 22,794 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.57 per share. | 15 Oct 2025 | 1,683 | 61,734 | - | 85.6 | 144,014 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2025 | 1,683 | 28,979 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 15 Oct 2025 | 1,683 | 63,417 | - | 18.9 | 31,859 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 20,000 | 30,662 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 13 Oct 2025 | 20,000 | 81,734 | - | 18.9 | 378,600 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 13,125 | 50,662 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 13 Oct 2025 | 13,125 | 81,734 | - | 18.9 | 248,456 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.75 per share. | 13 Oct 2025 | 12,280 | 69,454 | - | 85.8 | 1,053,010 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 88.73 per share. | 13 Oct 2025 | 12,266 | 63,330 | - | 88.7 | 1,088,362 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 13 Oct 2025 | 6,875 | 68,609 | - | 6.9 | 47,369 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2025 | 6,875 | 35,976 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 87.90 per share. | 13 Oct 2025 | 6,138 | 75,596 | - | 87.9 | 539,530 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 86.63 per share. | 13 Oct 2025 | 5,820 | 63,634 | - | 86.6 | 504,187 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 87.67 per share. | 13 Oct 2025 | 1,700 | 61,934 | - | 87.7 | 149,039 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 89.22 per share. | 13 Oct 2025 | 1,596 | 61,734 | - | 89.2 | 142,395 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 88.90 per share. | 13 Oct 2025 | 200 | 61,734 | - | 88.9 | 17,780 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.43 per share. | 01 Oct 2025 | 19,030 | 62,704 | - | 85.4 | 1,625,733 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 01 Oct 2025 | 16,787 | 78,521 | - | 6.9 | 115,662 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 16,787 | 42,851 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 3,213 | 63,787 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 01 Oct 2025 | 3,213 | 81,734 | - | 18.9 | 60,822 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 86.37 per share. | 01 Oct 2025 | 970 | 61,734 | - | 86.4 | 83,779 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 20,000 | 59,638 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.06 per share. | 29 Sep 2025 | 20,000 | 61,734 | - | 85.1 | 1,701,200 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 29 Sep 2025 | 20,000 | 81,734 | - | 6.9 | 137,800 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Sep 2025 | 7,588 | 79,638 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.01 per share. | 29 Sep 2025 | 7,588 | 61,734 | - | 85.0 | 645,056 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.89 per share. | 29 Sep 2025 | 7,588 | 69,322 | - | 6.9 | 52,281 | Class A Common Stock |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 14,700 | 67,000 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc (Class A) | Alexandra Balcom | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 85.10 per share. | 15 Jul 2025 | 14,700 | 61,734 | - | 85.1 | 1,250,970 | Class A Common Stock |